Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.

MLA

Saha, Amit, et al. “Safety and Immunogenicity Study of a Killed Bivalent (O1 and O139) Whole-Cell Oral Cholera Vaccine Shanchol, in Bangladeshi Adults and Children as Young as 1 Year of Age.” Vaccine, vol. 29, no. 46, Oct. 2011, pp. 8285–92. EBSCOhost, https://doi.org/10.1016/j.vaccine.2011.08.108.

APA

Saha, A., Chowdhury, M. I., Khanam, F., Bhuiyan, M. S., Chowdhury, F., Khan, A. I., Khan, I. A., Clemens, J., Ali, M., Cravioto, A., & Qadri, F. (2011). Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine, 29(46), 8285–8292. https://doi.org/10.1016/j.vaccine.2011.08.108

Chicago

Saha, Amit, Mohiul Islam Chowdhury, Farhana Khanam, Md Saruar Bhuiyan, Fahima Chowdhury, Ashraful Islam Khan, Iqbal Ansary Khan, et al. 2011. “Safety and Immunogenicity Study of a Killed Bivalent (O1 and O139) Whole-Cell Oral Cholera Vaccine Shanchol, in Bangladeshi Adults and Children as Young as 1 Year of Age.” Vaccine 29 (46): 8285–92. doi:10.1016/j.vaccine.2011.08.108.